Table 1. Demographic data of patient-derived cell lines.

Cell line	Pathologic diagnosis	Age*	Gender	Smoking (pk-yrs)	FVC (% pred)*	DLCO (% pred)*	TLC (% pred)*	Honeycomb on CT
Nonfibrotic controls
NF-1	Hamartoma	59	M	10	119	102	NA	No
NF-2	Lung CA	58	M	50	98	NA	NA	No
NF-3	Lung CA	53	M	20	88	NA	NA	No
Commercial nonfibrotic cell lines
CCL190	Nml lung, died of sarcoma	18	M
CCL204	Nml lung, died of astrocytoma	35	M
CCL210	Nml lung, died of head trauma	20	F
IPF
IPF-1	UIP	65	F	67.5	72	57	73	No
IPF-2	UIP	44	F	0	52	39	57	No
IPF-3	UIP	67	F	20	62	37	71	Yes
IPF-4	UIP	46	F	NA	39	29	49	No
IPF-5	UIP	70	M	25	48	35	56	No
IPF-6	UIP	Not available; de-identified lung from IPF patient obtained at time of transplant

*prior to biopsy; DLCO (diffusing capacity for carbon monoxide); TLC (total lung capacity); FVC (forced vital capacity).